HRP20150228T1 - Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe - Google Patents

Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe

Info

Publication number
HRP20150228T1
HRP20150228T1 HRP20150228AT HRP20150228T HRP20150228T1 HR P20150228 T1 HRP20150228 T1 HR P20150228T1 HR P20150228A T HRP20150228A T HR P20150228AT HR P20150228 T HRP20150228 T HR P20150228T HR P20150228 T1 HRP20150228 T1 HR P20150228T1
Authority
HR
Croatia
Prior art keywords
broad
novel piperazine
spectrum influenza
influenza antivirals
piperazine analogs
Prior art date
Application number
HRP20150228AT
Other languages
English (en)
Croatian (hr)
Inventor
Christopher W. Cianci
Samuel Gerritz
Guo Li
Bradley C. Pearce
Annapurna Pendri
Shuhao Shi
Weixu Zhai
Shirong Zhu
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HRP20150228T1 publication Critical patent/HRP20150228T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HRP20150228AT 2010-09-08 2011-09-06 Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe HRP20150228T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38072810P 2010-09-08 2010-09-08
PCT/US2011/050504 WO2012033736A1 (en) 2010-09-08 2011-09-06 Novel piperazine analogs as broad-spectrum influenza antivirals
EP11758034.0A EP2614052B1 (en) 2010-09-08 2011-09-06 Novel piperazine analogs as broad-spectrum influenza antivirals

Publications (1)

Publication Number Publication Date
HRP20150228T1 true HRP20150228T1 (hr) 2015-04-10

Family

ID=44653573

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150228AT HRP20150228T1 (hr) 2010-09-08 2011-09-06 Novi analozi piperazina kao antivirusna sredstva širokog spektra protiv virusa gripe

Country Status (17)

Country Link
US (1) US8362004B2 (enExample)
EP (1) EP2614052B1 (enExample)
JP (1) JP5902172B2 (enExample)
CN (1) CN103201268B (enExample)
BR (1) BR112013005552A2 (enExample)
CA (1) CA2809624A1 (enExample)
DK (1) DK2614052T3 (enExample)
EA (1) EA023258B1 (enExample)
ES (1) ES2533068T3 (enExample)
HR (1) HRP20150228T1 (enExample)
MX (1) MX2013002557A (enExample)
PL (1) PL2614052T3 (enExample)
PT (1) PT2614052E (enExample)
RS (1) RS53844B1 (enExample)
SI (1) SI2614052T1 (enExample)
SM (1) SMT201500068B (enExample)
WO (1) WO2012033736A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101369584B1 (ko) * 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
ES2664782T3 (es) * 2012-11-05 2018-04-23 Nantbio, Inc Derivados que contienen sulfonamida cíclica como inhibidores de la ruta de señalización de hedgehog
KR102089122B1 (ko) 2016-08-25 2020-03-13 주식회사 엘지화학 디아민 화합물 및 이를 이용하여 제조된 플렉시블 소자용 기판
JP2020506192A (ja) * 2017-02-02 2020-02-27 ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. インフルエンザウイルスを阻害するためのピペラジン誘導体
WO2018141854A1 (en) 2017-02-02 2018-08-09 Janssen Vaccines & Prevention B.V. Piperazine derivatives for influenza virus inhibition
WO2021204923A1 (en) * 2020-04-09 2021-10-14 Vironova Medical Ab Antiviral agents
WO2021204924A1 (en) * 2020-04-09 2021-10-14 Vironova Medical Ab Compounds for use in the treatment of hypercytokinemia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914371D0 (en) 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
WO2002102778A1 (en) * 2001-06-15 2002-12-27 Yamanouchi Pharmaceutical Co., Ltd. Phenylpyridine carbonyl piperazine derivative
ATE323702T1 (de) 2002-08-06 2006-05-15 Astrazeneca Ab Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
JP2006516656A (ja) 2003-01-28 2006-07-06 アヴェンティス ファーマ エス.エー. N−アリールヘテロ芳香族物質、それを含む組成物およびその用途
US6949865B2 (en) * 2003-01-31 2005-09-27 Betabatt, Inc. Apparatus and method for generating electrical current from the nuclear decay process of a radioactive material
GB0428235D0 (en) 2004-12-23 2005-01-26 Glaxo Group Ltd Novel compounds
EP1834954A1 (en) * 2006-03-15 2007-09-19 4Sc Ag Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
WO2011015037A1 (en) 2009-08-05 2011-02-10 The University Of Hongkong Antiviral compounds and methods of making and using there of cross reference to related applications

Also Published As

Publication number Publication date
DK2614052T3 (en) 2015-04-07
CN103201268B (zh) 2015-08-12
US20120238539A1 (en) 2012-09-20
JP5902172B2 (ja) 2016-04-13
MX2013002557A (es) 2013-05-28
EP2614052A1 (en) 2013-07-17
EA023258B1 (ru) 2016-05-31
ES2533068T3 (es) 2015-04-07
PL2614052T3 (pl) 2015-06-30
CA2809624A1 (en) 2012-03-15
EA201390362A1 (ru) 2013-07-30
SI2614052T1 (sl) 2015-04-30
SMT201500068B (it) 2015-05-05
PT2614052E (pt) 2015-03-31
US8362004B2 (en) 2013-01-29
EP2614052B1 (en) 2014-12-31
RS53844B1 (sr) 2015-08-31
JP2013537193A (ja) 2013-09-30
BR112013005552A2 (pt) 2016-05-03
WO2012033736A1 (en) 2012-03-15
CN103201268A (zh) 2013-07-10

Similar Documents

Publication Publication Date Title
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
IL236087A0 (en) n–aryltriazole compounds as lpar antagonists
GB201114103D0 (en) Novel compounds
GB201106799D0 (en) Novel compounds
IL236088A0 (en) n-Alkyltriazole compounds as lpar antagonists
GB201107325D0 (en) Novel compounds
GB201112607D0 (en) Novel compounds
ZA201309245B (en) Novel fluoroergoline analogs
GB201111704D0 (en) Novel compounds
EP2717694A4 (en) NEW COMPOUNDS
PL2614052T3 (pl) Nowe analogi piperazyny jako środki przeciw wirusowi grypy o szerokim spektrum
ZA201207903B (en) Novel benzamide derivatives
FR2967164B1 (fr) Procede de preparation de compositions a base de polypentosides
GB201105224D0 (en) Novel pharmaceutical compositions
IL223324A0 (en) Novel pharmaceutical compounds
GB201103074D0 (en) Novel compounds 1
GB201113450D0 (en) Novel compounds 60
GB201113448D0 (en) Novel compounds 61
GB201113443D0 (en) Novel compounds 62
GB201113441D0 (en) Novel compounds 64
GB201103075D0 (en) Novel compounds 3
GB201101824D0 (en) Novel heteroclyclic compounds 5
GB201101085D0 (en) Novel compounds
GB201106801D0 (en) Novel compounds
GB201104138D0 (en) Novel compounds